Pharming Intellectual Property B.V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pharming Intellectual Property B.V..The latest application filed is for "using c1 esterase inhibitor to treat viral infection-related acute respiratory distress".

Company Profile

2.13.16

Pharming Intellectual Property B.V. - Leiden NL
PHARMING INTELLECTUAL PROPERTY BV - NL NL
Pharming Intellectual Property BV - Leiden NL
Pharming Intellectual Property B.V. - Al Leiden NL
Pharming Intellectual Property BV - P.O. Box 451 Leiden NL
Pharming Intellectual Property B.V. - P.O. Box 451 NL_2300 Al Leiden NL
Pharming Intellectual Property BV - Al Leiden NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Using C1 Esterase Inhibitor To Treat Viral Infection-related Acute Respiratory Distress App 20210324107 - GIANNETTI; Bruno ; et al.	2021-10-21
Treatment and prevention of pre-eclampsia App 20200390872 - de Vries; Sijmen ; et al.	2020-12-17
Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals Grant 9,546,381 - Nelson , et al. January 17, 2	2017-01-17
Milking device Grant 9,408,366 - Salaheddine , et al. August 9, 2	2016-08-09
Use of C1 inhibitor for the prevention of ischemia-reperfusion injury Grant 9,211,318 - Mannesse , et al. December 15, 2	2015-12-15
Milking Device App 20140373786 - Salaheddine; Mourad ; et al.	2014-12-25
Treatment Of Bleeding With Low Half-Life Fibrinogen App 20130267466 - Pieper; Frank ; et al.	2013-10-10
Use Of C1 Inhibitor For The Prevention Of Ischemia-Reperfusion Injury App 20130244941 - Mannesse; Maurice ; et al.	2013-09-19
Use of C1 inhibitor for the prevention of ischemia-reperfusion injury Grant 8,415,288 - Mannesse , et al. April 9, 2	2013-04-09
Use of Anticoagulants in the Production of Recombinant Proteins in the Milk of Transgenic Animals App 20130053546 - Nelson; Kathryn Margaret ; et al.	2013-02-28
C1 inhibitor with short half-life transient treatment Grant RE43,691 - Nuijens September 25, 2	2012-09-25
Use Of C1 Inhibitor For The Prevention Of Ischemia-reperfusion Injury App 20120088728 - Mannesse; Maurice ; et al.	2012-04-12
Use of C1 inhibitor for the prevention of ischemia-reperfusion injury Grant 8,071,532 - Mannesse , et al. December 6, 2	2011-12-06
Treatment Of Bleeding With Low Half-life Fibrinogen App 20110263503 - Pieper; Frank ; et al.	2011-10-27
Production of fibrinogen in transgenic animals Grant RE42,704 - Prunkard , et al. September 13, 2	2011-09-13
Production of collagen in the milk of transgenic mammals App 20100305039 - Karatzas; Costas N. ; et al.	2010-12-02
C1 inhibitor with short half-life transient treatment Grant 7,544,853 - Nuijens June 9, 2	2009-06-09
Use of C1 Inhibitor for the Prevention of Ischemia-Reperfusion Injury App 20080305993 - Mannesse; Maurice ; et al.	2008-12-11
Fibrinogen from transgenic animals App 20070219352 - McCreath; Graham ; et al.	2007-09-20
C1 inhibitor with short half-life transient treatment App 20070185011 - Nuijens; Johannes Henricus	2007-08-09
Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography Grant 7,211,650 - McCreath , et al. May 1, 2	2007-05-01
C1 Inhibitor produced in the milk of transgenic non-human mammals Grant 7,067,713 - Nuijens , et al. June 27, 2	2006-06-27
Fusion proteins incorporating lysozyme Grant 7,045,677 - Cottingham , et al. May 16, 2	2006-05-16
C1 inhibitor produced in the milk of transgenic mammals App 20050223416 - Nuijens, Johannes Henricus ; et al.	2005-10-06
Production of collagen in the milk of transgenic mammals Grant 6,713,662 - Karatzas , et al. March 30, 2	2004-03-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.